Faruqi & Faruqi, LLP, a prominent securities law firm, is investigating potential claims against Metagenomi, Inc. (MGX) following the termination of its collaboration agreement with Moderna. Investors who suffered losses exceeding $50,000 during a specific period are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against Bumble Inc. following a series of disappointing financial reports. Investors who experienced losses exceeding $75,000 between November 7, 2023, and August 7, 2024, are urged to contact the firm directly to discuss their legal options.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against WEBTOON Entertainment Inc. (WBTN) following a significant drop in its stock price after the company reported disappointing financial results. Investors who suffered losses exceeding $50,000 are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a prominent national securities law firm, is conducting an investigation into potential securities law violations by AMMO, Inc. Investors who suffered losses exceeding $50,000 in AMMO between August 19, 2020 and September 24, 2024 are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against Bumble Inc. and encourages investors who suffered losses exceeding $75,000 to contact them directly. The firm is representing investors in a class action lawsuit alleging that Bumble misled investors about its financial performance and growth prospects. If you are an investor who has suffered losses due to Bumble’s alleged misrepresentations, contact Faruqi & Faruqi to discuss your legal options.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against United Parcel Service, Inc. (UPS) following a significant drop in stock price after UPS announced lower-than-expected financial results. Investors who suffered losses exceeding $100,000 between January 30, 2024, and July 22, 2024, are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AMMO, Inc. (POWW) for alleged violations of federal securities laws. The firm is encouraging investors who suffered losses exceeding $50,000 in AMMO between August 19, 2020, and September 24, 2024, to contact them to discuss their legal options. The investigation focuses on allegations that AMMO made false and misleading statements about its financial reporting and internal controls, potentially impacting investor decisions.
Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential legal claims against Elanco Animal Health Incorporated (ELAN). The firm encourages investors who suffered losses exceeding $100,000 due to alleged misstatements and omissions by Elanco between November 7, 2023, and June 26, 2024, to contact them directly. The lawsuit alleges that Elanco misled investors about the safety and timeline of its new products, Zenrelia and Credelio Quattro.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against Domino’s Pizza, Inc. after the company announced disappointing financial results and a significant reduction in its store growth forecast. Investors who suffered losses exceeding $100,000 in Domino’s stock between December 7, 2023 and July 17, 2024, are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP is investigating potential claims against Edwards Lifesciences Corporation (EW) for alleged securities law violations. The firm encourages investors who suffered losses exceeding $100,000 in Edwards between February 6, 2024, and July 24, 2024, to contact them directly. The lawsuit alleges that Edwards misled investors about the growth of its core product, Transcatheter Aortic Valve Replacement (TAVR), resulting in a significant stock price decline.
